Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through ...

Tennessee lawmakers considered several bills that directly affect students in the session that just ended. Here’s a roundup ...

The company stated it plans to launch PerQseal Elite in select European markets in Summer 2025. According to the company, the PerQseal Elite is a sutureless and fully bioresorbable large-bore vessel ...

Currently, there are no fully bioresorbable devices available for closure following large-bore procedures. Moreover, unlike other current devices, PerQseal Elite does not require any pre-procedure ...

Currently, there are no fully bioresorbable devices available for closure following large-bore procedures. Moreover, unlike other current devices, PerQseal Elite does not require any pre-procedure ...

More recent acquisitions have put Boston in the leadership role in several niche markets, including subcutaneous ICDs, interventional oncology, and left atrial appendage closure devices.

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...